The Enlargement of Abdominal Lymph Nodes Is a Characteristic of Autoimmune Liver Disease

Table 1

Baseline demographics and positive rates of abdominal lymphadenopathy in patients and healthy controls.

Diseases	Number	F/M	Mean age (y)	Patients with lymphadenopathy
AILD	125	(114/11)		87 (69.6%)	—
AIH	50	(45/5)		28 (56%)
PBC	29	(28/1)		25 (86.2%)	0.006
AIH-PBC	46	(41/5)		34 (73.9%)
Viral hepatitis	54	(28/26)		34 (63%)	0.306
CTD	135	(103/32)		40 (29.6%)	<0.001
Healthy	80	(48/32)		1 (2%)	<0.001

The positive rate of abdominal lymph node enlargement in different groups was compared by the test. The AILD group was compared with the viral hepatitis, CTD, and health groups, respectively, and was statistically significant. The PBC group was compared with the AIH group. AILD: autoimmune liver disease; AIH: autoimmune hepatitis; PBC: primary biliary cholangitis; AIH-PBC: overlap syndrome; CTD: connective tissue diseases.